The trend: AI pilots are accelerating among healthcare and pharma companies—but only about 30% of AI proofs-of-concept have reached production, according to a new report from Bessemer Venture Partners, Amazon Web Services, and Bain & Company. Over 400 decision makers at healthcare provider organizations, pharma companies, and health insurance firms were surveyed for the report.

Digging into the data: Respondents are piloting AI across clinical, patient care, marketing, sales, revenue cycle, claims, and more. Respondents also have the resources to launch AI pilots: 60% of respondents report seeing genAI budgets grow faster than overall IT budgets.

Yes, but: Most healthcare AI projects are stuck in the experimentation stages.